Institutions Holding Put Options on Novo Cure LTD (NVCR)
This table provides information about the put option holders of Novo Cure LTD (NVCR). We have compiled data on the institutions that hold put options on the stock, with a total of 831,800 put options outstanding, which have been reported (via 13F filing form) to have a value of $14.2 Million at the end of the reported quarter. These put option holders have the right, but not the obligation, to sell AAPL shares at a specified price within a certain time frame.
Holding | Report Date | puts Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 07, 2024 Q1 2024 |
240,100
puts
|
$4.11 Million
0.0% of portfolio
|
Q1 2024
Reduced 38.02%
|
|
Caption Management, LLC
Oklahoma City, OK |
May 15, 2024 Q1 2024 |
196,200
puts
|
$3.36 Million
0.05% of portfolio
|
Q1 2024
New holding
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
161,500
puts
|
$2.77 Million
0.0% of portfolio
|
Q1 2024
Added 92.49%
|
|
Hap Trading, LLC
New York, NY |
May 13, 2024 Q1 2024 |
120,100
puts
|
$2.06 Million
0.0% of portfolio
|
Q1 2024
New holding
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2024 Q1 2024 |
41,300
puts
|
$707,469
0.0% of portfolio
|
Q1 2024
New holding
|
|
Wolverine Trading, LLC
Chicago, IL |
May 15, 2024 Q1 2024 |
27,300
puts
|
$467,649
0.0% of portfolio
|
Q1 2024
Added 141.59%
|
|
Capital Fund Management S.A.
Paris, I0 |
May 15, 2024 Q1 2024 |
23,500
puts
|
$402,555
0.0% of portfolio
|
Q1 2024
Reduced 52.62%
|
|
Ubs Group Ag
|
May 13, 2024 Q1 2024 |
11,000
puts
|
$188,430
0.0% of portfolio
|
Q1 2024
Reduced 92.36%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2024 Q1 2024 |
10,200
puts
|
$174,726
0.0% of portfolio
|
Q1 2024
Reduced 47.42%
|
|
Wolverine Asset Management LLC
|
May 13, 2024 Q1 2024 |
500
puts
|
$8,565
0.0% of portfolio
|
Q1 2024
Reduced 95.19%
|
|
Walleye Capital LLC
Plymouth, MN |
May 15, 2024 Q1 2024 |
100
puts
|
$1,713
0.0% of portfolio
|
Q1 2024
Reduced 93.75%
|